Selected research
Industry Growth & Trends
Global Nucleic Acids for Molecular Diagnosis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Nucleic Acids for Molecular Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nucleic Acids for Molecular Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nucleic Acids for Molecular Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nucleic Acids for Molecular Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Nucleic Acids for Molecular Diagnosis market include Agilent Technologies, Inc., Aji Bio-Pharma, Bio-synthesis Inc., Danaher Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Kaneka Eurogentec S.A., L.G.C Biosearch Technologies and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nucleic Acids for Molecular Diagnosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nucleic Acids for Molecular Diagnosis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nucleic Acids for Molecular Diagnosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nucleic Acids for Molecular Diagnosis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nucleic Acids for Molecular Diagnosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nucleic Acids for Molecular Diagnosis Market by Company
Agilent Technologies, Inc.
Aji Bio-Pharma
Bio-synthesis Inc.
Danaher Corporation
Eurofins Scientific SE
Integrated DNA Technologies
Kaneka Eurogentec S.A.
L.G.C Biosearch Technologies
Merck KGaA
metabion
QIAGEN
Thermo Fisher Scientific Inc.
Hongene
Synthgene
Nucleic Acids for Molecular Diagnosis Segment by Type
DNA Series
RNA Series
Nucleic Acids for Molecular Diagnosis Segment by Application
Early Cancer Screening
Genetic Diseases
Blood Screening
Genome Sequencing
Infectious Diseases
Other
Nucleic Acids for Molecular Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acids for Molecular Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acids for Molecular Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acids for Molecular Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nucleic Acids for Molecular Diagnosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Global Nucleic Acids for Molecular Diagnosis Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032
Table 2. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & (US$ Million)
Table 3. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2021-2026)
Table 4. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2027-2032) & (US$ Million)
Table 5. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2027-2032)
Table 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 7. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & (US$ Million)
Table 8. Global Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2026)
Table 9. Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Type (2027-2032) & (US$ Million)
Table 10. Global Nucleic Acids for Molecular Diagnosis Market Size Share Forecasted by Type (2027-2032)
Table 11. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 12. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 13. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 14. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 15. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 16. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 17. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 18. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 19. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 20. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 21. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 22. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & (US$ Million)
Table 23. Global Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2026)
Table 24. Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Application (2027-2032) & (US$ Million)
Table 25. Global Nucleic Acids for Molecular Diagnosis Market Size Share Forecasted by Application (2027-2032)
Table 26. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 27. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 28. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 29. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 30. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 31. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 32. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 33. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 34. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 35. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 36. Nucleic Acids for Molecular Diagnosis Industry Trends
Table 37. Nucleic Acids for Molecular Diagnosis Industry Drivers
Table 38. Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges
Table 39. Nucleic Acids for Molecular Diagnosis Industry Restraints
Table 40. Global Nucleic Acids for Molecular Diagnosis Revenue by Company (US$ Million) & (2021-2026)
Table 41. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Company (2021-2026)
Table 42. Global Nucleic Acids for Molecular Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026
Table 43. Global Nucleic Acids for Molecular Diagnosis Key Company Headquarters & Area Served
Table 44. Global Nucleic Acids for Molecular Diagnosis Company, Product Type & Application
Table 45. Global Nucleic Acids for Molecular Diagnosis Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Nucleic Acids for Molecular Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 48. Agilent Technologies, Inc. Company Information
Table 49. Agilent Technologies, Inc. Business Overview
Table 50. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 51. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 52. Agilent Technologies, Inc. Recent Development
Table 53. Aji Bio-Pharma Company Information
Table 54. Aji Bio-Pharma Business Overview
Table 55. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 56. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 57. Aji Bio-Pharma Recent Development
Table 58. Bio-synthesis Inc. Company Information
Table 59. Bio-synthesis Inc. Business Overview
Table 60. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 61. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 62. Bio-synthesis Inc. Recent Development
Table 63. Danaher Corporation Company Information
Table 64. Danaher Corporation Business Overview
Table 65. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 66. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 67. Danaher Corporation Recent Development
Table 68. Eurofins Scientific SE Company Information
Table 69. Eurofins Scientific SE Business Overview
Table 70. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 71. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 72. Eurofins Scientific SE Recent Development
Table 73. Integrated DNA Technologies Company Information
Table 74. Integrated DNA Technologies Business Overview
Table 75. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 76. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 77. Integrated DNA Technologies Recent Development
Table 78. Kaneka Eurogentec S.A. Company Information
Table 79. Kaneka Eurogentec S.A. Business Overview
Table 80. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 81. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 82. Kaneka Eurogentec S.A. Recent Development
Table 83. L.G.C Biosearch Technologies Company Information
Table 84. L.G.C Biosearch Technologies Business Overview
Table 85. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 86. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 87. L.G.C Biosearch Technologies Recent Development
Table 88. Merck KGaA Company Information
Table 89. Merck KGaA Business Overview
Table 90. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 91. Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 92. Merck KGaA Recent Development
Table 93. metabion Company Information
Table 94. metabion Business Overview
Table 95. metabion Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 96. metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 97. metabion Recent Development
Table 98. QIAGEN Company Information
Table 99. QIAGEN Business Overview
Table 100. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 101. QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 102. QIAGEN Recent Development
Table 103. Thermo Fisher Scientific Inc. Company Information
Table 104. Thermo Fisher Scientific Inc. Business Overview
Table 105. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 106. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 107. Thermo Fisher Scientific Inc. Recent Development
Table 108. Hongene Company Information
Table 109. Hongene Business Overview
Table 110. Hongene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 111. Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 112. Hongene Recent Development
Table 113. Synthgene Company Information
Table 114. Synthgene Business Overview
Table 115. Synthgene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 116. Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 117. Synthgene Recent Development
Table 118. North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 119. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million)
Table 120. North America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2026)
Table 121. North America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 122. North America Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2027-2032)
Table 123. Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 124. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million)
Table 125. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2026)
Table 126. Europe Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 127. Europe Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2027-2032)
Table 128. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 129. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million)
Table 130. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2026)
Table 131. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 132. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2027-2032)
Table 133. Latin America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 134. Latin America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million)
Table 135. Latin America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2026)
Table 136. Latin America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 137. Latin America Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2027-2032)
Table 138. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 139. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million)
Table 140. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2026)
Table 141. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 142. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2027-2032)
Table 143. Research Programs/Design for This Report
Table 144. Authors List of This Report
Table 145. Secondary Sources
List of Figures
Figure 1.List of Figures
Figure 2. Nucleic Acids for Molecular Diagnosis Product Image
Figure 3. Global Nucleic Acids for Molecular Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 4. Global Nucleic Acids for Molecular Diagnosis Market Size (2021-2032) & (US$ Million)
Figure 5. Global Nucleic Acids for Molecular Diagnosis Market Share by Region: 2025 VS 2032
Figure 6. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2021-2032)
Figure 7. North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 8. Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 9. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 10. Latin America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 11. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 12. DNA Series Image
Figure 13. Global DNA Series Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 14. RNA Series Image
Figure 15. Global RNA Series Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 16. Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 17. Global Nucleic Acids for Molecular Diagnosis Market Share by Type 2025 VS 2032
Figure 18. North America Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2032)
Figure 19. Europe Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2032)
Figure 20. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2032)
Figure 21. Latin America Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2032)
Figure 22. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2021-2032)
Figure 23. Early Cancer Screening Image
Figure 24. Global Early Cancer Screening Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Genetic Diseases Image
Figure 26. Global Genetic Diseases Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Blood Screening Image
Figure 28. Global Blood Screening Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Genome Sequencing Image
Figure 30. Global Genome Sequencing Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Infectious Diseases Image
Figure 32. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Other Image
Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 36. Global Nucleic Acids for Molecular Diagnosis Market Share by Application 2025 VS 2032
Figure 37. North America Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2032)
Figure 38. Europe Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2032)
Figure 39. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2032)
Figure 40. Latin America Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2032)
Figure 41. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2021-2032)
Figure 42. Global Top 5 and 10 Nucleic Acids for Molecular Diagnosis Players Market Share by Revenue in 2025
Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 44. North America Nucleic Acids for Molecular Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 45. North America Nucleic Acids for Molecular Diagnosis Market Share by Country: 2021 VS 2025 VS 2032
Figure 46. North America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032)
Figure 47. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 48. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country: 2021 VS 2025 VS 2032
Figure 49. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032)
Figure 50. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 51. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Country: 2021 VS 2025 VS 2032
Figure 52. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032)
Figure 53. Latin America Nucleic Acids for Molecular Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 54. Latin America Nucleic Acids for Molecular Diagnosis Market Share by Country: 2021 VS 2025 VS 2032
Figure 55. Latin America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032)
Figure 56. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 57. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share by Country: 2021 VS 2025 VS 2032
Figure 58. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032)
Figure 59. Years Considered
Figure 60. Research Process
Figure 61. Key Executives Interviewed
Scope & coverage.
Types
- DNA Series
- RNA Series
Applications
- Early Cancer Screening
- Genetic Diseases
- Blood Screening
- Genome Sequencing
- Infectious Diseases
- Other
Companies covered
- Agilent Technologies, Inc.
- Aji Bio-Pharma
- Bio-synthesis Inc.
- Danaher Corporation
- Eurofins Scientific SE
- Integrated DNA Technologies
- Kaneka Eurogentec S.A.
- L.G.C Biosearch Technologies
- Merck KGaA
- metabion
- QIAGEN
- Thermo Fisher Scientific Inc.
- Hongene
- Synthgene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2032)
- 1.4.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026)
- 1.4.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2027-2032)
- 1.5 Key Regions Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
- 1.5.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032)
2 Nucleic Acids for Molecular Diagnosis Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA Series
- 2.1.2 RNA Series
- 2.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Type
- 2.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
- 2.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2021-2026)
3 Nucleic Acids for Molecular Diagnosis Market by Application
- 3.1 Type Introduction
- 3.1.1 Early Cancer Screening
- 3.1.2 Genetic Diseases
- 3.1.3 Blood Screening
- 3.1.4 Genome Sequencing
- 3.1.5 Infectious Diseases
- 3.1.6 Other
- 3.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Application
- 3.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
- 3.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nucleic Acids for Molecular Diagnosis Industry Trends
- 4.2 Nucleic Acids for Molecular Diagnosis Industry Drivers
- 4.3 Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges
- 4.4 Nucleic Acids for Molecular Diagnosis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nucleic Acids for Molecular Diagnosis Revenue (2021-2026)
- 5.2 Global Nucleic Acids for Molecular Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nucleic Acids for Molecular Diagnosis Key Company Headquarters & Area Served
- 5.4 Global Nucleic Acids for Molecular Diagnosis Company, Product Type & Application
- 5.5 Global Nucleic Acids for Molecular Diagnosis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nucleic Acids for Molecular Diagnosis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nucleic Acids for Molecular Diagnosis Players Market Share by Revenue in 2025
- 5.6.3 2025 Nucleic Acids for Molecular Diagnosis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Agilent Technologies, Inc.
- 6.1.1 Agilent Technologies, Inc. Company Information
- 6.1.2 Agilent Technologies, Inc. Business Overview
- 6.1.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.1.5 Agilent Technologies, Inc. Recent Developments
- 6.2 Aji Bio-Pharma
- 6.2.1 Aji Bio-Pharma Company Information
- 6.2.2 Aji Bio-Pharma Business Overview
- 6.2.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.2.5 Aji Bio-Pharma Recent Developments
- 6.3 Bio-synthesis Inc.
- 6.3.1 Bio-synthesis Inc. Company Information
- 6.3.2 Bio-synthesis Inc. Business Overview
- 6.3.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.3.5 Bio-synthesis Inc. Recent Developments
- 6.4 Danaher Corporation
- 6.4.1 Danaher Corporation Company Information
- 6.4.2 Danaher Corporation Business Overview
- 6.4.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.4.5 Danaher Corporation Recent Developments
- 6.5 Eurofins Scientific SE
- 6.5.1 Eurofins Scientific SE Company Information
- 6.5.2 Eurofins Scientific SE Business Overview
- 6.5.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.5.5 Eurofins Scientific SE Recent Developments
- 6.6 Integrated DNA Technologies
- 6.6.1 Integrated DNA Technologies Company Information
- 6.6.2 Integrated DNA Technologies Business Overview
- 6.6.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.6.5 Integrated DNA Technologies Recent Developments
- 6.7 Kaneka Eurogentec S.A.
- 6.7.1 Kaneka Eurogentec S.A. Company Information
- 6.7.2 Kaneka Eurogentec S.A. Business Overview
- 6.7.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.7.5 Kaneka Eurogentec S.A. Recent Developments
- 6.8 L.G.C Biosearch Technologies
- 6.8.1 L.G.C Biosearch Technologies Company Information
- 6.8.2 L.G.C Biosearch Technologies Business Overview
- 6.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.8.5 L.G.C Biosearch Technologies Recent Developments
- 6.9 Merck KGaA
- 6.9.1 Merck KGaA Company Information
- 6.9.2 Merck KGaA Business Overview
- 6.9.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.9.5 Merck KGaA Recent Developments
- 6.10 metabion
- 6.10.1 metabion Company Information
- 6.10.2 metabion Business Overview
- 6.10.3 metabion Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.10.5 metabion Recent Developments
- 6.11 QIAGEN
- 6.11.1 QIAGEN Company Information
- 6.11.2 QIAGEN Business Overview
- 6.11.3 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.11.5 QIAGEN Recent Developments
- 6.12 Thermo Fisher Scientific Inc.
- 6.12.1 Thermo Fisher Scientific Inc. Company Information
- 6.12.2 Thermo Fisher Scientific Inc. Business Overview
- 6.12.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.12.5 Thermo Fisher Scientific Inc. Recent Developments
- 6.13 Hongene
- 6.13.1 Hongene Company Information
- 6.13.2 Hongene Business Overview
- 6.13.3 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.13.5 Hongene Recent Developments
- 6.14 Synthgene
- 6.14.1 Synthgene Company Information
- 6.14.2 Synthgene Business Overview
- 6.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
- 6.14.5 Synthgene Recent Developments
7 North America
- 7.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
- 7.3 North America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
- 8.3 Europe Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
- 10.3 South America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst